Trump Administration Tightens Green Card Process Foreign Nationals May Need to Leave US for Applications USChina Trade Tensions Persist After APEC Three Signs of Divergence Global Markets Rally as Iran Peace Progress Boosts Investor Sentiment Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Highlight CNBC Morning Squawk AI Stocks Plunge as Chinas DeepSeek Sparks Broad Market Rout India Government Plans Major Overhaul of Tax Administration to Facilitate Smooth GST Rollout CCLD Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines COLL Q1 2026 Earnings EPS Beats Estimates by 843 as Collegium Posts 176 WERN Q1 2026 Earnings Earnings Beat with Positive Surprise Amid Weak Demand Ashland Inc ASH Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions Lindblad Expeditions Holdings Inc LIND Q1 2026 Earnings Strong Profit Beat Drives Share Rally Orange County Bancorp Inc OBT Q1 2026 Earnings EPS Beats Estimates by 72 as Community Bank Outperforms Nuveen California AMTFree Quality Municipal Income Fund NKX Edges Higher Amid Modest Upward Momentum Highview Merger Corp HVMC Holds Steady at 1012 as Investors Await Catalysts Bank OZK OZK Edges Lower as Shares Trade in Tight Range Support at 4574 Holds Crexendo CXDO Holds Near Resistance as Trading Remains Subdued Janus Henderson Group JHG Holds Steady Near Resistance as Volume Remains Modest BioOrbit Launches DrugCrystallisation Technology to Space for Cancer Treatment Production BLNK Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Huntington Bancshares Preferred Stock HBANL Holds Steady Near Midpoint of Trading Range VTAK Q1 2025 Earnings Significant EPS Miss Amidst Operational Challenges FTAIM Q1 2026 Earnings EPS Falls Short of Estimates Preferred Shares Unchanged Envela Corporation ELA Q1 2026 Earnings Strong EPS Surprise of 2285 Despite Modest Stock Decline ITGR Q1 2026 Earnings EPS Slightly Misses Estimates Amid Mixed Conditions Simpson Manufacturing Q1 2026 Earnings EPS Beats Estimates by 1285 as Profitability Holds Firm TSHA Q1 2026 Earnings EPS Miss Highlights Ongoing DevelopmentStage Challenges MiNK Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid Clinical Progress